Literature DB >> 21496369

The effects of flow on airway pressure during nasal high-flow oxygen therapy.

Rachael L Parke1, Michelle L Eccleston, Shay P McGuinness.   

Abstract

BACKGROUND: Nasal high-flow oxygen therapy increases the mean nasopharyngeal airway pressure in adults, but the relationship between flow and pressure is not well defined.
OBJECTIVE: To determine the relationship between flow and pressure with the Optiflow nasal high-flow oxygen therapy system.
METHODS: We invited patients scheduled for elective cardiac surgery to participate. Measurements were performed with nasal high-flow oxygen at flows of 30, 40, and 50 L/min, with the patient's mouth both open and closed. Pressures were recorded over one minute of breathing, and average flows were calculated via simple averaging.
RESULTS: With the mouth closed, the mean ± SD airway pressures at 30, 40, and 50 L/min were 1.93 ± 1.25 cm H(2)O, 2.58 ± 1.54 cm H(2)O, and 3.31 ± 1.05 cm H(2)O, respectively. There was a positive linear relationship between flow and pressure.
CONCLUSIONS: The mean nasopharyngeal pressure during nasal high-flow oxygen increases as flow increases. Australian Clinical Trials Registry http://www.adhb.govt.nz/achicu/hot_2_airway_pressure.htm.

Entities:  

Mesh:

Year:  2011        PMID: 21496369     DOI: 10.4187/respcare.01106

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  76 in total

1.  Nasal high flow oxygen therapy after extubation: the road is open but don't drive too fast!

Authors:  Antoine Rabbat; Kim Blanc; Aurélie Lefebvre; Christine Lorut
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  High-flow oxygen therapy for the management of patients with acute exacerbation of cystic fibrosis.

Authors:  Arnaud W Thille; Florent Joly; Nicolas Marjanovic; Jean-Pierre Frat
Journal:  Ann Transl Med       Date:  2018-12

3.  Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials.

Authors:  Xiaofeng Ou; Yusi Hua; Jin Liu; Cansheng Gong; Wenling Zhao
Journal:  CMAJ       Date:  2017-02-21       Impact factor: 8.262

4.  High-flow nasal cannula oxygen therapy in acute hypoxemic respiratory failure: Proceed with caution.

Authors:  Shailesh Bihari; Andrew D Bersten
Journal:  CMAJ       Date:  2017-02-21       Impact factor: 8.262

5.  High-flow oxygen via tracheostomy improves oxygenation in patients weaning from mechanical ventilation: a randomised crossover study.

Authors:  Amanda Corley; Melannie Edwards; Amy J Spooner; Kimble R Dunster; Chris Anstey; John F Fraser
Journal:  Intensive Care Med       Date:  2016-11-30       Impact factor: 17.440

6.  Perioperative respiratory complications: current evidence and strategy discussed in 2017 JA symposium.

Authors:  K Hirota; M Yamakage; S Hashimoto; T Asai; S Isono
Journal:  J Anesth       Date:  2017-11-13       Impact factor: 2.078

7.  Passive continuous positive airway pressure ventilation during cardiopulmonary resuscitation: a randomized cross-over manikin simulation study.

Authors:  Bernd E Winkler; Ralf M Muellenbach; Thomas Wurmb; Manuel F Struck; Norbert Roewer; Peter Kranke
Journal:  J Clin Monit Comput       Date:  2016-02-09       Impact factor: 2.502

8.  Direct extubation onto high-flow nasal cannulae post-cardiac surgery versus standard treatment in patients with a BMI ≥30: a randomised controlled trial.

Authors:  Amanda Corley; Taressa Bull; Amy J Spooner; Adrian G Barnett; John F Fraser
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

Review 9.  High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure.

Authors:  Jean-Pierre Frat; Rémi Coudroy; Nicolas Marjanovic; Arnaud W Thille
Journal:  Ann Transl Med       Date:  2017-07

10.  High-Flow, Heated, Humidified Air Via Nasal Cannula Treats CPAP-Intolerant Children With Obstructive Sleep Apnea.

Authors:  Stephen Hawkins; Stephanie Huston; Kristen Campbell; Ann Halbower
Journal:  J Clin Sleep Med       Date:  2017-08-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.